中文

News & Events

Dr. Tan won the Special Contribution Award of "Overseas Chinese Innovation and Entrepreneurship List"
2017-07-13Return>>
On July 9th, 2017, Dr. Tan Lingshi, Chairman & CEO of dMed Biopharmaceutical Co., Ltd. won the Special Contribution Award of "Overseas Chinese Innovation and Entrepreneurship Elite" presented by Conference on Overseas Chinese Pioneering and Developing in China. The International biomedical seminar of the Conference was held at the Bio-Park Exhibition Center of Optical Valley in Wuhan.



This conference has been held for 16 times since 2000, and this year is the first time that the Conference set up the "Overseas Chinese Innovation and Entrepreneurship List", which aims to recognize nine distinguished scientists and entrepreneurs who have made outstanding contributions to the biomedical territory.

The elite list consists of three awards including innovation breakthrough award, personal achievement award and special contribution award. The Conference Assembly promulgated the "Special Contribution Award" to Dr. Tan in recognition of his years of active participation and support of biomedical industry construction and development for optical valley. Dr. Tan drove and directed the successful settlement of Pfizer Wuhan R&D Center project, and gave rise to the butterfly effect of biomedical industry development at optical Valley in Wuhan.

Dr. Tan founded dMed Biopharmaceutical Co., Ltd in 2016. He is committed to the attraction of global R&D talents in pharmaceuticals and continuous improvement of the quality clinical Research & Development to promote the progress and development of the biomedical industry.

780 Cailun Road, 6/F, Q Zhangjiang Hi-Tech Park, Pudong, Shanghai 201203, China
Tel: +86 21 5090 0085 Fax: +86 21 6875 5515
沪ICP备16041651号-1 Copyright © 2016 dMed All Rights Reserved
沪公网安备 31011502005403号